close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gelteq Limited - Ordinary Shares (NQ:GELS)

0.5395 -0.0614 (-10.22%)
Streaming Delayed Price Updated: 9:52 AM EDT, Sep 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gelteq Limited - Ordinary Shares

< Previous 1 2 3 Next >
What's going on in today's session ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
These stocks are moving in today's after hours session ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Gelteq (NASDAQ:GELS) shares increased by 38.6% to $0.97 during Thursday's pre-market session. The company's market cap stands at $7.4 million. bioAffinity Technologies (NASDAQ:BIAF) shares... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednesday's regular session. The company's market cap stands at $3.9 million. Gelteq (NASDAQ:GELS) shares... 
Via Benzinga
Unusual volume stocks are being observed in Monday's session. ↗
Via Chartmill
Monday's session: top gainers and losers ↗
Via Chartmill
Gapping stocks in Monday's session ↗
Via Chartmill
Monday's pre-market session: top gainers and losers ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Unusual volume stocks in Friday's session ↗
Via Chartmill
Friday's session: top gainers and losers ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
Top movers in Thursday's after hours session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-14: top gainers and losers in today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China ↗
Gelteq signed a three-year agreement with Shenzhen Mana Health Management to distribute its sugar-lowering nutritional products in China, guaranteeing approximately $1.3 million in minimum revenue. 
Via Stocktwits
News headline image
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform ↗
Gelteq announced preclinical results demonstrating its proprietary gel platform significantly improved the absorption and bioavailability of poorly soluble drugs. 
Via Stocktwits
News headline image
Gelteq to Present at Investor Summit Virtual on December 9, 2025 ↗
Gelteq Limited CEO, Nathan Givoni, is scheduled to present updates on the company's growth strategy and market positioning at the Q4 Investor Summit Virtual on December 9, 2025. 
Via Stocktwits
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.